Shannon K. Oda

Seattle Children's Hospital

Also affiliated with Center for Cancer and Blood Disorders

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy”.

Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.30.454539

N/A

0DataRank · unranked

3 citations

Shannon K. Oda, Breanna M. Bates, Madison G. Burnett, Magdalia Rodgers Suarez, Susan L. Ruskin +2 more

Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003959

N/A

0DataRank · unranked

25 citations

Shannon K. Oda, Breanna M. Bates, Madison G. Burnett, Magdalia Rodgers Suarez, Susan L. Ruskin +2 more

TGF-β broadly modifies rather than specifically suppresses reactivated memory CD8 T cells in a dose-dependent manner

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2313228120

N/A

0DataRank · unranked

24 citations

A Konecny, Shannon K. Oda, James Scott‐Browne, Martin Prlic, Alexis K Taber